Pathophysiology and therapy of irinotecan (CPT-11) induced delayed onset diarrhea (DD): A prospective assessment

被引：0
|
作者：
Misset, JL
Saliba, F
Giacchetti, S
Brain, E
Vassal, G
Bonnay, M
Bastian, G
Cote, C
Mahjoubi, M
Herait, P
Hagipantelli, R
Cvitkovic, E
机构：
[1] HOP PAUL BROUSSE,VILLEJUIF,FRANCE
[2] IGR,VILLEJUIF,FRANCE
[3] SOMPS,PARIS,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：742 / 742
页数：1
相关论文
共 50 条
  • [1] Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea
    K. Takasuna
    T. Hagiwara
    K. Watanabe
    S. Onose
    S. Yoshida
    E. Kumazawa
    E. Nagai
    T. Kamataki
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 494 - 503
  • [2] Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea
    Takasuna, K.
    Hagiwara, T.
    Watanabe, K.
    Onose, S.
    Yoshida, S.
    Kumazawa, E.
    Nagai, E.
    Kamataki, T.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 494 - 503
  • [3] Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: A prospective assessment
    Saliba, F
    Hagipantelli, R
    Misset, JL
    Bastian, G
    Vassal, G
    Bonnay, M
    Herait, P
    Cote, C
    Mahjoubi, M
    Mignard, D
    Cvitkovic, E
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2745 - 2751
  • [4] Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats
    Akinobu Kurita
    Shoichi Kado
    Norimasa Kaneda
    Masaharu Onoue
    Shusuke Hashimoto
    Teruo Yokokura
    Cancer Chemotherapy and Pharmacology, 2000, 46 : 211 - 220
  • [5] Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats
    Kurita, A
    Kado, S
    Kaneda, N
    Onoue, M
    Hashimoto, S
    Yokokura, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (03) : 211 - 220
  • [6] Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea
    Ikegami, T
    Ha, L
    Arimori, K
    Latham, P
    Kobayashi, K
    Ceryak, S
    Matsuzaki, Y
    Bouscarel, B
    CANCER RESEARCH, 2002, 62 (01) : 179 - 187
  • [7] Effect of intestinal alkalinization on Irinotecan (CPT-11)-induced diarrhea in the golden Syrian hamster model
    Ikegami, T
    Latham, P
    Kobayashi, K
    Arimori, K
    Bouscarel, B
    GASTROENTEROLOGY, 2001, 120 (05) : A613 - A613
  • [8] Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients
    Takeda, Y
    Kobayashi, K
    Akiyama, Y
    Soma, T
    Handa, S
    Kudoh, S
    Kudo, K
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (02) : 269 - 275
  • [9] Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
    Swami, Umang
    Goel, Sanjay
    Mani, Sridhar
    CURRENT DRUG TARGETS, 2013, 14 (07) : 777 - 797
  • [10] Nursing management of irinotecan (CPT-11) induced side-effects
    Buda, P
    Arosti, O
    Bevegni, A
    Pisani, R
    Iacono, G
    Da Chà, M
    Tudisco, R
    Zappardino, A
    Inghilleri, A
    Carpanelli, I
    Visone, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S41 - S41
12345